Synthesis, structure and biological evaluation of mixed ligand oxidovanadium(iv) complexes incorporating 2-(arylazo)phenolates-Reference-Cited by-同舟云学术

Synthesis, structure and biological evaluation of mixed ligand oxidovanadium(iv) complexes incorporating 2-(arylazo)phenolates

Published:2019 Issue:45 Volume:43 Page:17711-17725
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Lima Sudhir¹²³⁴,Banerjee Atanu¹²³⁴,Mohanty Monalisa¹²³⁴,Sahu Gurunath¹²³⁴,Kausar Chahat⁵²³⁴,Patra Samir Kumar⁵²³⁴,Garribba Eugenio⁶⁷⁸⁹^ORCID,Kaminsky Werner¹¹⁰¹¹¹²^ORCID,Dinda Rupam¹²³⁴^ORCID

Affiliation:

1. Department of Chemistry

2. National Institute of Technology

3. Rourkela

4. India

5. Department of Life Science

6. Dipartimento di Chimica e Farmacia

7. Università di Sassari

8. I-07100 Sassari

9. Italy

10. University of Washington

11. Seattle

12. USA

Abstract

Synthesis and characterization of mixed ligand oxidovanadium(iv) complexes [V^IVO(L^1–4)(L^NN)] incorporating arylazo ligands: evaluation of DNA/BSA interaction and cytotoxicity activity.

Funder

Department of Biotechnology, Ministry of Science and Technology

Council of Scientific and Industrial Research, India

Regione Autonoma della Sardegna

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2019/NJ/C9NJ01910C

Reference146 articles.

1. The resurgence of platinum-based cancer chemotherapy

2. Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs

3. Challenges and Opportunities in the Development of Organometallic Anticancer Drugs

4. Exploration of the medical periodic table: towards new targets

5. K. R. Barnes and S. J.Lippard Metal Complexes in Tumor Diagnosis and as Anticancer Agents , Marcel Dekker , New York/Basel , 2004 , vol. 42, p. 179

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising in vitro and in silico biological activity of tetradentate Schiff base copper(ii) complexes with a propylenediamine bridge;New Journal of Chemistry;2024

2. Hydrolytically Stable Ti^IV–Hydrazone-Based Metallodrugs: Protein Interaction and Anticancer Potential;ACS Applied Bio Materials;2023-11-29

3. A Series of Non-Oxido V^IVComplexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity;Inorganic Chemistry;2023-05-08

4. LV^VO-Ethyl Maltol-Based Metallodrugs (L^2– = Tridentate ONO Ligands): Hydrophobicity, Hydrolytic Stability, and Cytotoxicity via ROS-Mediated Apoptosis;Inorganic Chemistry;2023-04-19

5. Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death;Chemistry – A European Journal;2023-02-24